![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Pierre Fabre Medicament Gaillac Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for The 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group.
One of their significant offerings is Mucoproteose, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-050 - Rev 00
This TSE Type CEP, issued on March 01, 2007, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.